EP300/CBP-IN-2

• UNSPSC Description:

  EP300/CBP-IN-2 is a potent EP300/CBP inhibitor that has good activity in vivo. EP300/CBP-IN-2 can be used for the research of cancer[1].

• Target Antigen:

  Epigenetic Reader Domain

• Type:

  Isotope-Labeled Compounds

• Related Pathways:

  Epigenetics

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C1N(C2=CC(F)=C(C=C2)F)[C@@H](CCC1)C3=NC4=CC(C5=C(C)ON=C5C)=CC=C4N3[C@@H]6CC[C@H](CC6)OC([2H])([2H])[2H]

• Molecular Weight:

  537.62

• References & Citations:

  [1]Fan L, et al. Deuterated benzimidazole compound and application thereof as EP300/CBP inhibitor. China, CN112574178A. 2021-03-30.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2379527-49-6